 | • レポートコード：GIR-2104Z07455 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、免疫腫瘍薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。免疫腫瘍薬の種類別市場規模（免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン、腫瘍溶解性ウイルス、その他）、用途別市場規模（病院、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・免疫腫瘍薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen, Inc、AstraZeneca, Plc、Bristol-Myers Squibb、Celgene Corporation、Eli Lilly and Company、Merck & Co.、Hoffmann-La Roche AG、Johnson & Johnson、Novartis International AG、AbbVie, Inc.、Pfizer Inc.、Sanofi S.A.、EMD Serono, Inc.、Gilead Sciences Inc.、Prometheus Therapeutics & Diagnostics、Aduro BioTech、Galena Biopharma、Bavarian Nordic、Celldex Therapeutics、ImmunoCellular Therapeutics、Incyte、Dendreon Corporation、Agilent Technologies Inc.、Agenus Inc.、Enzo Biochem, Inc.、Lonza Group、Bio-Rad Laboratories, Inc.、Avantor, Inc.、Spring Bank Pharmaceuticals, Inc.、Ferring Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン、腫瘍溶解性ウイルス、その他 ・用途別分析2016年-2026年：病院、クリニック、外来手術センター ・免疫腫瘍薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・免疫腫瘍薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・免疫腫瘍薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・免疫腫瘍薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・免疫腫瘍薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Immuno-oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Immuno-oncology Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Immuno-oncology Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Immuno-oncology Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
Others
Market segment by Application can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
The key market players for global Immuno-oncology Drugs market are listed below:
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Dendreon Corporation
Agilent Technologies Inc.
Agenus Inc.
Enzo Biochem, Inc.
Lonza Group
Bio-Rad Laboratories, Inc.
Avantor, Inc.
Spring Bank Pharmaceuticals, Inc.
Ferring Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Immuno-oncology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immuno-oncology Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.2.5 Oncolytic Virus
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Immuno-oncology Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Immuno-oncology Drugs Market Size & Forecast
1.4.1 Global Immuno-oncology Drugs Sales in Value (2016-2026))
1.4.2 Global Immuno-oncology Drugs Sales in Volume (2016-2026)
1.4.3 Global Immuno-oncology Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Immuno-oncology Drugs Production Capacity Analysis
1.5.1 Global Immuno-oncology Drugs Total Production Capacity (2016-2026)
1.5.2 Global Immuno-oncology Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immuno-oncology Drugs Market Drivers
1.6.2 Immuno-oncology Drugs Market Restraints
1.6.3 Immuno-oncology Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen, Inc
2.1.1 Amgen, Inc Details
2.1.2 Amgen, Inc Major Business
2.1.3 Amgen, Inc Immuno-oncology Drugs Product and Services
2.1.4 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AstraZeneca, Plc
2.2.1 AstraZeneca, Plc Details
2.2.2 AstraZeneca, Plc Major Business
2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Product and Services
2.2.4 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
2.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Immuno-oncology Drugs Product and Services
2.4.4 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Immuno-oncology Drugs Product and Services
2.5.4 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Immuno-oncology Drugs Product and Services
2.6.4 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Hoffmann-La Roche AG
2.7.1 Hoffmann-La Roche AG Details
2.7.2 Hoffmann-La Roche AG Major Business
2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
2.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Immuno-oncology Drugs Product and Services
2.8.4 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Novartis International AG
2.9.1 Novartis International AG Details
2.9.2 Novartis International AG Major Business
2.9.3 Novartis International AG Immuno-oncology Drugs Product and Services
2.9.4 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 AbbVie, Inc.
2.10.1 AbbVie, Inc. Details
2.10.2 AbbVie, Inc. Major Business
2.10.3 AbbVie, Inc. Immuno-oncology Drugs Product and Services
2.10.4 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Immuno-oncology Drugs Product and Services
2.11.4 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Sanofi S.A.
2.12.1 Sanofi S.A. Details
2.12.2 Sanofi S.A. Major Business
2.12.3 Sanofi S.A. Immuno-oncology Drugs Product and Services
2.12.4 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 EMD Serono, Inc.
2.13.1 EMD Serono, Inc. Details
2.13.2 EMD Serono, Inc. Major Business
2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Product and Services
2.13.4 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Gilead Sciences Inc.
2.14.1 Gilead Sciences Inc. Details
2.14.2 Gilead Sciences Inc. Major Business
2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
2.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Prometheus Therapeutics & Diagnostics
2.15.1 Prometheus Therapeutics & Diagnostics Details
2.15.2 Prometheus Therapeutics & Diagnostics Major Business
2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
2.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Aduro BioTech
2.16.1 Aduro BioTech Details
2.16.2 Aduro BioTech Major Business
2.16.3 Aduro BioTech Immuno-oncology Drugs Product and Services
2.16.4 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Galena Biopharma
2.17.1 Galena Biopharma Details
2.17.2 Galena Biopharma Major Business
2.17.3 Galena Biopharma Immuno-oncology Drugs Product and Services
2.17.4 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Bavarian Nordic
2.18.1 Bavarian Nordic Details
2.18.2 Bavarian Nordic Major Business
2.18.3 Bavarian Nordic Immuno-oncology Drugs Product and Services
2.18.4 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Celldex Therapeutics
2.19.1 Celldex Therapeutics Details
2.19.2 Celldex Therapeutics Major Business
2.19.3 Celldex Therapeutics Immuno-oncology Drugs Product and Services
2.19.4 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 ImmunoCellular Therapeutics
2.20.1 ImmunoCellular Therapeutics Details
2.20.2 ImmunoCellular Therapeutics Major Business
2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
2.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Incyte
2.21.1 Incyte Details
2.21.2 Incyte Major Business
2.21.3 Incyte Immuno-oncology Drugs Product and Services
2.21.4 Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Dendreon Corporation
2.22.1 Dendreon Corporation Details
2.22.2 Dendreon Corporation Major Business
2.22.3 Dendreon Corporation Immuno-oncology Drugs Product and Services
2.22.4 Dendreon Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Agilent Technologies Inc.
2.23.1 Agilent Technologies Inc. Details
2.23.2 Agilent Technologies Inc. Major Business
2.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Product and Services
2.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.24 Agenus Inc.
2.24.1 Agenus Inc. Details
2.24.2 Agenus Inc. Major Business
2.24.3 Agenus Inc. Immuno-oncology Drugs Product and Services
2.24.4 Agenus Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.25 Enzo Biochem, Inc.
2.25.1 Enzo Biochem, Inc. Details
2.25.2 Enzo Biochem, Inc. Major Business
2.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Product and Services
2.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.26 Lonza Group
2.26.1 Lonza Group Details
2.26.2 Lonza Group Major Business
2.26.3 Lonza Group Immuno-oncology Drugs Product and Services
2.26.4 Lonza Group Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.27 Bio-Rad Laboratories, Inc.
2.27.1 Bio-Rad Laboratories, Inc. Details
2.27.2 Bio-Rad Laboratories, Inc. Major Business
2.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product and Services
2.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.28 Avantor, Inc.
2.28.1 Avantor, Inc. Details
2.28.2 Avantor, Inc. Major Business
2.28.3 Avantor, Inc. Immuno-oncology Drugs Product and Services
2.28.4 Avantor, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.29 Spring Bank Pharmaceuticals, Inc.
2.29.1 Spring Bank Pharmaceuticals, Inc. Details
2.29.2 Spring Bank Pharmaceuticals, Inc. Major Business
2.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product and Services
2.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.30 Ferring Pharmaceuticals
2.30.1 Ferring Pharmaceuticals Details
2.30.2 Ferring Pharmaceuticals Major Business
2.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Product and Services
2.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Immuno-oncology Drugs Sales by Manufacturer
3.1 Global Immuno-oncology Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Immuno-oncology Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Immuno-oncology Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Immuno-oncology Drugs Manufacturer Market Share
3.4.2 Top 6 Immuno-oncology Drugs Manufacturer Market Share
3.5 Global Immuno-oncology Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Immuno-oncology Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immuno-oncology Drugs Market Size by Region
4.1.1 Global Immuno-oncology Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Immuno-oncology Drugs Revenue by Region (2016-2026)
4.2 North America Immuno-oncology Drugs Revenue (2016-2026)
4.3 Europe Immuno-oncology Drugs Revenue (2016-2026)
4.4 Asia-Pacific Immuno-oncology Drugs Revenue (2016-2026)
4.5 South America Immuno-oncology Drugs Revenue (2016-2026)
4.6 Middle East and Africa Immuno-oncology Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Immuno-oncology Drugs Sales in Volume by Type (2016-2026)
5.2 Global Immuno-oncology Drugs Revenue by Type (2016-2026)
5.3 Global Immuno-oncology Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Immuno-oncology Drugs Sales in Volume by Application (2016-2026)
6.2 Global Immuno-oncology Drugs Revenue by Application (2016-2026)
6.3 Global Immuno-oncology Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Immuno-oncology Drugs Sales by Type (2016-2026)
7.2 North America Immuno-oncology Drugs Sales by Application (2016-2026)
7.3 North America Immuno-oncology Drugs Market Size by Country
7.3.1 North America Immuno-oncology Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Immuno-oncology Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Immuno-oncology Drugs Sales by Type (2016-2026)
8.2 Europe Immuno-oncology Drugs Sales by Application (2016-2026)
8.3 Europe Immuno-oncology Drugs Market Size by Country
8.3.1 Europe Immuno-oncology Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Immuno-oncology Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Immuno-oncology Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Immuno-oncology Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Immuno-oncology Drugs Market Size by Region
9.3.1 Asia-Pacific Immuno-oncology Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Immuno-oncology Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Immuno-oncology Drugs Sales by Type (2016-2026)
10.2 South America Immuno-oncology Drugs Sales by Application (2016-2026)
10.3 South America Immuno-oncology Drugs Market Size by Country
10.3.1 South America Immuno-oncology Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Immuno-oncology Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immuno-oncology Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Immuno-oncology Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Immuno-oncology Drugs Market Size by Country
11.3.1 Middle East & Africa Immuno-oncology Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Immuno-oncology Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Immuno-oncology Drugs Typical Distributors
12.3 Immuno-oncology Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Immuno-oncology Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Immuno-oncology Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Amgen, Inc Major Business
Table 5. Amgen, Inc Immuno-oncology Drugs Product and Services
Table 6. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca, Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca, Plc Major Business
Table 9. AstraZeneca, Plc Immuno-oncology Drugs Product and Services
Table 10. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
Table 14. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Celgene Corporation Major Business
Table 17. Celgene Corporation Immuno-oncology Drugs Product and Services
Table 18. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Major Business
Table 21. Eli Lilly and Company Immuno-oncology Drugs Product and Services
Table 22. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 24. Merck & Co. Major Business
Table 25. Merck & Co. Immuno-oncology Drugs Product and Services
Table 26. Merck & Co. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 28. Hoffmann-La Roche AG Major Business
Table 29. Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
Table 30. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Major Business
Table 33. Johnson & Johnson Immuno-oncology Drugs Product and Services
Table 34. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 36. Novartis International AG Major Business
Table 37. Novartis International AG Immuno-oncology Drugs Product and Services
Table 38. Novartis International AG Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 40. AbbVie, Inc. Major Business
Table 41. AbbVie, Inc. Immuno-oncology Drugs Product and Services
Table 42. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc. Major Business
Table 45. Pfizer Inc. Immuno-oncology Drugs Product and Services
Table 46. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi S.A. Major Business
Table 49. Sanofi S.A. Immuno-oncology Drugs Product and Services
Table 50. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. EMD Serono, Inc. Basic Information, Manufacturing Base and Competitors
Table 52. EMD Serono, Inc. Major Business
Table 53. EMD Serono, Inc. Immuno-oncology Drugs Product and Services
Table 54. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Gilead Sciences Inc. Major Business
Table 57. Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
Table 58. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base and Competitors
Table 60. Prometheus Therapeutics & Diagnostics Major Business
Table 61. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
Table 62. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Aduro BioTech Basic Information, Manufacturing Base and Competitors
Table 64. Aduro BioTech Major Business
Table 65. Aduro BioTech Immuno-oncology Drugs Product and Services
Table 66. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Galena Biopharma Basic Information, Manufacturing Base and Competitors
Table 68. Galena Biopharma Major Business
Table 69. Galena Biopharma Immuno-oncology Drugs Product and Services
Table 70. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 72. Bavarian Nordic Major Business
Table 73. Bavarian Nordic Immuno-oncology Drugs Product and Services
Table 74. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 76. Celldex Therapeutics Major Business
Table 77. Celldex Therapeutics Immuno-oncology Drugs Product and Services
Table 78. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. ImmunoCellular Therapeutics Major Business
Table 81. ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
Table 82. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Incyte Basic Information, Manufacturing Base and Competitors
Table 84. Incyte Major Business
Table 85. Incyte Immuno-oncology Drugs Product and Services
Table 86. Incyte Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 88. Dendreon Corporation Major Business
Table 89. Dendreon Corporation Immuno-oncology Drugs Product and Services
Table 90. Dendreon Corporation Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Agilent Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Agilent Technologies Inc. Major Business
Table 93. Agilent Technologies Inc. Immuno-oncology Drugs Product and Services
Table 94. Agilent Technologies Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Agenus Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Agenus Inc. Major Business
Table 97. Agenus Inc. Immuno-oncology Drugs Product and Services
Table 98. Agenus Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Enzo Biochem, Inc. Basic Information, Manufacturing Base and Competitors
Table 100. Enzo Biochem, Inc. Major Business
Table 101. Enzo Biochem, Inc. Immuno-oncology Drugs Product and Services
Table 102. Enzo Biochem, Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 104. Lonza Group Major Business
Table 105. Lonza Group Immuno-oncology Drugs Product and Services
Table 106. Lonza Group Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 108. Bio-Rad Laboratories, Inc. Major Business
Table 109. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product and Services
Table 110. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Avantor, Inc. Basic Information, Manufacturing Base and Competitors
Table 112. Avantor, Inc. Major Business
Table 113. Avantor, Inc. Immuno-oncology Drugs Product and Services
Table 114. Avantor, Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 115. Spring Bank Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Spring Bank Pharmaceuticals, Inc.Major Business
Table 117. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product and Services
Table 118. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 119. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 120. Ferring Pharmaceuticals Major Business
Table 121. Ferring Pharmaceuticals Immuno-oncology Drugs Product and Services
Table 122. Ferring Pharmaceuticals Immuno-oncology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 123. Global Immuno-oncology Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 124. Global Immuno-oncology Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 125. Market Position of Manufacturers in Immuno-oncology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 126. Global Immuno-oncology Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 127. Head Office and Immuno-oncology Drugs Production Site of Key Manufacturer
Table 128. Global Immuno-oncology Drugs Sales by Region (2016-2021e) & (K Units)
Table 129. Global Immuno-oncology Drugs Sales by Region (2021-2026) & (K Units)
Table 130. Global Immuno-oncology Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 131. Global Immuno-oncology Drugs Revenue by Region (2021-2026) & (USD Million)
Table 132. Global Immuno-oncology Drugs Sales by Type (2016-2021e) & (K Units)
Table 133. Global Immuno-oncology Drugs Sales by Type (2021-2026) & (K Units)
Table 134. Global Immuno-oncology Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 135. Global Immuno-oncology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 136. Global Immuno-oncology Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 137. Global Immuno-oncology Drugs Price by Type (2021-2026) & (USD/Unit)
Table 138. Global Immuno-oncology Drugs Sales by Application (2016-2021e) & (K Units)
Table 139. Global Immuno-oncology Drugs Sales by Application (2021-2026) & (K Units)
Table 140. Global Immuno-oncology Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 141. Global Immuno-oncology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 142. Global Immuno-oncology Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 143. Global Immuno-oncology Drugs Price by Application (2021-2026) & (USD/Unit)
Table 144. North America Immuno-oncology Drugs Sales by Country (2016-2021e) & (K Units)
Table 145. North America Immuno-oncology Drugs Sales by Country (2021-2026) & (K Units)
Table 146. North America Immuno-oncology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 147. North America Immuno-oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 148. North America Immuno-oncology Drugs Sales by Type (2016-2021e) & (K Units)
Table 149. North America Immuno-oncology Drugs Sales by Type (2021-2026) & (K Units)
Table 150. North America Immuno-oncology Drugs Sales by Application (2016-2021e) & (K Units)
Table 151. North America Immuno-oncology Drugs Sales by Application (2021-2026) & (K Units)
Table 152. Europe Immuno-oncology Drugs Sales by Country (2016-2021e) & (K Units)
Table 153. Europe Immuno-oncology Drugs Sales by Country (2021-2026) & (K Units)
Table 154. Europe Immuno-oncology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 155. Europe Immuno-oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 156. Europe Immuno-oncology Drugs Sales by Type (2016-2021e) & (K Units)
Table 157. Europe Immuno-oncology Drugs Sales by Type (2021-2026) & (K Units)
Table 158. Europe Immuno-oncology Drugs Sales by Application (2016-2021e) & (K Units)
Table 159. Europe Immuno-oncology Drugs Sales by Application (2021-2026) & (K Units)
Table 160. Asia-Pacific Immuno-oncology Drugs Sales by Region (2016-2021e) & (K Units)
Table 161. Asia-Pacific Immuno-oncology Drugs Sales by Region (2021-2026) & (K Units)
Table 162. Asia-Pacific Immuno-oncology Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 163. Asia-Pacific Immuno-oncology Drugs Revenue by Region (2021-2026) & (USD Million)
Table 164. Asia-Pacific Immuno-oncology Drugs Sales by Type (2016-2021e) & (K Units)
Table 165. Asia-Pacific Immuno-oncology Drugs Sales by Type (2021-2026) & (K Units)
Table 166. Asia-Pacific Immuno-oncology Drugs Sales by Application (2016-2021e) & (K Units)
Table 167. Asia-Pacific Immuno-oncology Drugs Sales by Application (2021-2026) & (K Units)
Table 168. South America Immuno-oncology Drugs Sales by Country (2016-2021e) & (K Units)
Table 169. South America Immuno-oncology Drugs Sales by Country (2021-2026) & (K Units)
Table 170. South America Immuno-oncology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 171. South America Immuno-oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 172. South America Immuno-oncology Drugs Sales by Type (2016-2021e) & (K Units)
Table 173. South America Immuno-oncology Drugs Sales by Type (2021-2026) & (K Units)
Table 174. South America Immuno-oncology Drugs Sales by Application (2016-2021e) & (K Units)
Table 175. South America Immuno-oncology Drugs Sales by Application (2021-2026) & (K Units)
Table 176. Middle East & Africa Immuno-oncology Drugs Sales by Country (2016-2021e) & (K Units)
Table 177. Middle East & Africa Immuno-oncology Drugs Sales by Country (2021-2026) & (K Units)
Table 178. Middle East & Africa Immuno-oncology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 179. Middle East & Africa Immuno-oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 180. Middle East & Africa Immuno-oncology Drugs Sales by Type (2016-2021e) & (K Units)
Table 181. Middle East & Africa Immuno-oncology Drugs Sales by Type (2021-2026) & (K Units)
Table 182. Middle East & Africa Immuno-oncology Drugs Sales by Application (2016-2021e) & (K Units)
Table 183. Middle East & Africa Immuno-oncology Drugs Sales by Application (2021-2026) & (K Units)
Table 184. Direct Channel Pros & Cons
Table 185. Indirect Channel Pros & Cons
Table 186. Immuno-oncology Drugs Typical Distributors
Table 187. Immuno-oncology Drugs Typical Customers
List of Figures
Figure 1. Immuno-oncology Drugs Picture
Figure 2. Global Immuno-oncology Drugs Sales Market Share by Type in 2020
Figure 3. Immune Checkpoint Inhibitors
Figure 4. Immune System Modulators
Figure 5. Cancer Vaccines
Figure 6. Oncolytic Virus
Figure 7. Others
Figure 8. Global Immuno-oncology Drugs Sales Market Share by Application in 2020
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Ambulatory Surgical Centers
Figure 12. Global Immuno-oncology Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Immuno-oncology Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Immuno-oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Immuno-oncology Drugs Sales (2016-2026) & (K Units)
Figure 34. Global Immuno-oncology Drugs Production Capacity (2016-2026) & (K Units)
Figure 35. Global Immuno-oncology Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Immuno-oncology Drugs Market Drivers
Figure 37. Immuno-oncology Drugs Market Restraints
Figure 38. Immuno-oncology Drugs Market Trends
Figure 39. Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Immuno-oncology Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Immuno-oncology Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Immuno-oncology Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Immuno-oncology Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Immuno-oncology Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Immuno-oncology Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Immuno-oncology Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Immuno-oncology Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Immuno-oncology Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Immuno-oncology Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Immuno-oncology Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Immuno-oncology Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Immuno-oncology Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Immuno-oncology Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Immuno-oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Immuno-oncology Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Immuno-oncology Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Immuno-oncology Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Immuno-oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Immuno-oncology Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Immuno-oncology Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Immuno-oncology Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Immuno-oncology Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Immuno-oncology Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Immuno-oncology Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Immuno-oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Immuno-oncology Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Immuno-oncology Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Immuno-oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の免疫腫瘍療法市場規模・現状・予測（2021年-2027年） Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer. Market Analysis and Insights: Global Immuno-oncology Therapy Market The global Immuno-oncology Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a …- 世界のがん免疫療法市場 2021：企業別、地域別、種類・用途別 The Immuno-oncology Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の免疫腫瘍治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immuno-Oncology Treatment Market The global Immuno-Oncology Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. Market Analysis and Insights: Global Drugs for Oncology Market The global Drugs for Oncology market size is …
- 世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. Market Analysis and Insights: Global Drugs for Oncology Market The global Drugs for Oncology market size is …